ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2017

Emerging use of combination therapies for the management of type 2 diabetes - focus on saxagliptin and dapagliflozin.

Huan Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.